May 14, 2026 a 12:38 pm

BSX: Analysts Ratings - Boston Scientific Corporation

Historical Stock Grades

In the most recent analysis dated May 1, 2026, Boston Scientific received a substantial number of 'Buy' and 'Strong Buy' recommendations, emphasizing the market's confidence in the company's outlook. The ratings breakdown is detailed below:

Rating Type	Count	Score
Strong Buy	9
Buy	23
Hold	2
Sell	0
Strong Sell	0

Sentiment Development

Over recent months, the number of analyst ratings for Boston Scientific has seen some variation but generally maintains a positive tilt.

• The overall volume of ratings has stayed relatively consistent, with minor fluctuations.
• There was a slight reduction in 'Strong Buy' ratings but a concurrent increase in standard 'Buy' ratings.
• 'Hold' rates remained marginally low, while there were no 'Sell' or 'Strong Sell' recommendations in the latest data.

Percentage Trends

The trends show a subtle but significant shift in how analysts view BSX, reflecting broader market sentiments.

• Compared to twelve months ago, there's been a decrease in 'Strong Buy' ratings, from 12 to 9.
• 'Buy' ratings have seen a slight uptrend, adjusting to 23 from 15, suggesting increased confidence.
• The persistent absence of 'Sell' ratings indicates a stable outlook and growing trust in the company's performance.

Latest Analyst Recommendations

The latest analyst activities reflect consistent outlooks, with several firms maintaining their prior positive ratings:

Date	New Recommendation	Last Recommendation	Publisher
2026-04-23	Outperform	Outperform	Baird
2026-04-23	Overweight	Overweight	Barclays
2026-04-23	Buy	Buy	Needham
2026-04-23	Buy	Buy	Goldman Sachs
2026-04-23	Buy	Buy	Truist Securities

Analyst Recommendations with Change of Opinion

Recent recommendations indicate evolving perceptions among analysts, with some notable changes:

Date	New Recommendation	Last Recommendation	Publisher
2026-03-30	Outperform	Strong Buy	Raymond James
2025-09-08	Outperform	Perform	Oppenheimer
2025-04-16	Buy	Hold	Needham
2024-10-18	Hold	Buy	Needham
2024-02-01	Buy	Neutral	Mizuho

Interpretation

The strong positive sentiment from analysts toward Boston Scientific Corporation suggests an optimistic market evaluation of the company's potential and stability. The lack of 'Sell' ratings and the prevalence of 'Buy' endorsements indicate confidence in the business's capacity for sustained growth. Where changes do occur, they often reflect strategic repositioning rather than a decline in confidence, demonstrating that analyst opinion, while subject to change, remains robust for BSX.

Conclusion

Boston Scientific Corporation is currently viewed favorably among analysts, with substantial existing market confidence supported by strong insider and external analysis. While there is a slight downturn in 'Strong Buy' recommendations, the overall sentiment remains highly positive, suggesting performance consistency. Potential investors should weigh these ratings against Boston Scientific's competitive position in the medical device sector, but current indicators suggest an overall beneficial landscape with significant upside potential.